June, 2024
June 2024
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
Nancy Lin: Updated data for Pfizer cdk4-selective inhibitor PF-07220060
May 19, 2024, 05:46

Nancy Lin: Updated data for Pfizer cdk4-selective inhibitor PF-07220060

Nancy Lin, Associate Chief of Division of Breast Oncology at Susan F. Smith Center for Women’s Cancers, shared on X:

“Updated data for Pfizer cdk4-selective inhibitor PF-07220060.

  • patient population: 100% prior cdk4/6i
  • favorable tox profile
  • 32% ORR, median PFS 8.1 months
  • efficacy regardless of ESR1 and PIK3CA mutation status.”

 cdk4-selective

Source: Nancy Lin/X